- Report
- March 2025
- 174 Pages
United States
From €7215EUR$7,995USD£6,269GBP
- Report
- September 2024
- 117 Pages
Global
From €4061EUR$4,500USD£3,528GBP
- Report
- June 2024
- 363 Pages
Global
From €3610EUR$4,000USD£3,136GBP
- Report
- August 2023
- 292 Pages
Europe
From €8118EUR$8,995USD£7,053GBP
- Report
- March 2023
- 251 Pages
United States
From €7215EUR$7,995USD£6,269GBP
- Report
- September 2020
- 700 Pages
Global
From €4422EUR$4,900USD£3,842GBP
From €3159EUR$3,500USD£2,744GBP
- Report
- December 2024
- 150 Pages
Global
From €3030EUR$3,358USD£2,632GBP
€3565EUR$3,950USD£3,097GBP
- Report
- February 2026
- 105 Pages
Global
From €3500EUR$4,155USD£3,147GBP
- Report
- July 2023
- 94 Pages
Global
From €3500EUR$4,155USD£3,147GBP
From €116EUR$129USD£101GBP
Tissue Regeneration is a field of biotechnology that focuses on the development of techniques to replace or regenerate damaged or diseased tissues and organs. It involves the use of stem cells, biomaterials, and other biological components to create new tissues and organs. This technology has the potential to revolutionize the treatment of many diseases, including cancer, heart disease, and diabetes.
Tissue Regeneration is a rapidly growing field, with many companies investing in research and development. Companies are developing new technologies to improve the efficacy of tissue regeneration, such as 3D printing, gene editing, and nanotechnology. These technologies are being used to create new organs and tissues, as well as to improve existing treatments.
Some companies in the Tissue Regeneration market include Organovo, BioTime, and Osiris Therapeutics. These companies are developing new technologies to improve the efficacy of tissue regeneration, as well as to create new organs and tissues. Other companies in the market include Celgene, Vertex Pharmaceuticals, and Athersys. Show Less Read more
